CleanTech Lithium (CTL), an exploration and development company, announced it has completed the planned acquisition of the 23 Laguna Verde licences previously subject to an option agreement resulting in the Company
CleanTech Lithium (CTL), an exploration and development company, announced it has completed the planned acquisition of the 23 Laguna Verde licences previously subject to an option agreement resulting in the Company
CleanTech Lithium (CTL), an exploration and development company advancing lithium projects in Chile, confirmed the drilling of the second well has started in the recently commenced drilling programme at Laguna Verde.
It is difficult to look forward to 2024 without some degree of trepidation. After all, just because 2023 was exceptionally bad for most small caps, we are not necessarily due
In 2023, gold reached an unprecedented high, with silver following its ascent. Experts see no major obstacles to gold’s continued upward trend this year.
Tekmar Group (TGP) a second and more significant new contract is announced in as many months. A £3.5m contract for its flagship Generation 10 cable protection system (CPS) with associated ancillaries
ANGLE PLC (AIM: AGL, OTCQX: ANPCY), a specialist in liquid biopsy, announced a significant advancement in cancer diagnostics, offering more personalized and actionable insights into the disease and its progression.
Panthera Resources (PAT), with gold assets in West Africa and India, announced that the Company’s Australian subsidiary, Indo Gold Pty Ltd has formally issued a Notice of Dispute to the Republic
Pensana (PRE) advised that on 29 August 2023, 30 August 2023 and 31 August 2023, Paul Atherley purchased shares in the company.
In wider market trends, the AIM-All Share Index experienced a decrease of 2.4%, dipping to 792. Similarly, London’s top-tier FTSE 100 companies saw a decline of 2.1%, settling at 7,587.
ANGLE PLC (AIM: AGL, OTCQX: ANPCY), a leader in liquid biopsy technology, has revealed a major contract acquisition with Artios Pharma.
Overall, the AIM All-Shares Index closed the week down by half a percent, underperforming against the FTSE 100 and FTSE 350 indices, which both closed around half a percent higher.
ANGLE PLC (AIM: AGL, OTCQX: ANPCY), a liquid biopsy company, announced that it achieved a significant milestone in 2022, with clearance from the US Food & Drug Administration (FDA) and